Protagonist Therapeutics Inc (PTGX)

Return on assets (ROA)

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Net income (ttm)	US$ in thousands	162,110	-78,955	-140,484	-137,611	-140,188	-127,393	-130,106	-132,678	-122,483	-125,551	-107,530	-81,489	-70,068	-66,150	-64,765	-73,411	-83,164	-77,187	-73,551	-65,877
Total assets	US$ in thousands	629,276	357,951	330,016	320,466	239,858	247,928	282,174	310,512	348,296	347,695	373,175	404,232	298,072	324,468	217,320	224,980	134,901	154,917	154,627	148,105
ROA		25.76%	-22.06%	-42.57%	-42.94%	-58.45%	-51.38%	-46.11%	-42.73%	-35.17%	-36.11%	-28.81%	-20.16%	-23.51%	-20.39%	-29.80%	-32.63%	-61.65%	-49.82%	-47.57%	-44.48%

March 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $162,110K ÷ $629,276K
= 25.76%

Protagonist Therapeutics Inc's return on assets (ROA) has shown significant volatility over the provided periods. The ROA ranged from a high of 25.76% on March 31, 2024, to a low of -61.65% on March 31, 2020. The negative ROA figures indicate that the company's net income was insufficient to cover its total assets in those periods.

The positive ROA on March 31, 2024, suggests that the company generated a healthy return relative to its assets at that point. However, the negative ROA in previous periods raises concerns about the company's profitability and efficient asset utilization.

Overall, the fluctuating ROA figures highlight the challenges Protagonist Therapeutics Inc has faced in generating consistent profits relative to its asset base. Further analysis of the company's financial performance and operational efficiency may be necessary to understand the factors driving these ROA fluctuations.